Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

Bazarbachi AH, Lentzsch S, Facon T, Harousseau JL, Mohty M

Open source

DOI
10.1200/jco-26-00545
Published
2026 Sep 10
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-00545,
  title = {Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.},
  author = {Bazarbachi AH and Lentzsch S and Facon T and Harousseau JL and Mohty M},
  year = {2026},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco-26-00545},
  url = {https://doi.org/10.1200/jco-26-00545}
}

RIS

TY  - JOUR
TI  - Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.
AU  - Bazarbachi AH
AU  - Lentzsch S
AU  - Facon T
AU  - Harousseau JL
AU  - Mohty M
PY  - 2026
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco-26-00545
UR  - https://doi.org/10.1200/jco-26-00545
ER  - 

APA

AH, B., S, L., T, F., JL, H., & M, M. (2026). Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-26-00545

Source records